$0.6400
0.0713.25%
At close: -
$0.6278
-0.01-1.91%
After Hours: Dec 20, 5:45 PM EDT
Comments
Loading...
NKGen Biotech (NASDAQ:NKGN) Stock, Earnings Estimates, EPS, And Revenue
NKGen Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Sep 12
EPS
$-0.670
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of NKGen Biotech using advanced sorting and filters.
Data brought to you by Benzinga APIs
NKGen Biotech (NKGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
NKGen Biotech (NKGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NKGen Biotech (NASDAQ:NKGN) reporting earnings?
NKGen Biotech (NKGN) is scheduled to report earnings on January 3, 2025. The last reported earnings were for reported on September 12, 2024 for Q2.
What were the latest earnings per share (EPS) for NKGen Biotech (NASDAQ:NKGN)?
The Actual EPS was $-0.67, which missed the estimate of $0.00.
What were NKGen Biotech’s (NASDAQ:NKGN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.